NCT02972372Recruiting
Chemoradiation Versus Esophagectomy for Locally Advanced Esophageal Cancer
A Randomized, Open-label, Multicenter Trial of the Chemoradiation Versus Standard Esophagectomy for Locally Advanced Resectable Esophageal Squamous Cell Cancer in Chinese Patients
Source: ClinicalTrials.gov · Last updated 10 Feb 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The aim of this study is to compare outcomes in Chinese patients with locally advanced resectable esophageal squamous cell cancer who have received either surgery or definitive chemoradiation (CRT) by the randomized, open-label, multicenter trial.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 196 (estimated)
- First submitted
- 6 Nov 2016
- Start date
- Nov 2016
- Primary completion date
- Dec 2025
- Lead sponsor
- The First Affiliated Hospital of Henan University of Science and Technology
- Diseases
- Gastric and esophageal cancer
- NCT number
- NCT02972372
What you commit to
- Study type: Interventional
- Planned participants: 196
- From Nov 2016 to the primary completion date, Dec 2025
- 2 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- who had a serious premorbid condition or a poor physical status that compromised a thoracotomy.
Other
- who had distant metastasis to solid visceral organs or local invasion into trachea, descending aorta, or recurrent laryngeal nerve.
Who the study is looking for
- Chinese
- esophageal squamous cell cancer
- mid or lower esophageal cancer
- tumor is resectable disease
- clinical stage: cT1bN+Mo, or cT2-4aN0-2M0
Age in the registry: 18 years to 75 years · Sex: All · Does not accept healthy volunteers
Sites (2)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Anyang Tumor Hospital Coordinator of this site? Confirm its status | Anyang | China | Recruiting |
| The First Affiliated Hospital, and College of Clinical Medicine of Henan University of Science and Technology Coordinator of this site? Confirm its status | Luoyang | China | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.